Pharmaceutical intermediates are the drugs used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry.
6-Paradol: Physicochemical properties, sources and related research
6-Paradol is a phenolic compound found in plants of the Zingiberaceae family that possesses a pungent flavour; it is used in food flavouring, and there is also research into its anti-inflammatory, neu
Nov 4，2026 Pharmaceutical intermediates
Preliminary Study on Synthesis and Applications of 3-Phenylpyruvic Acid
3-Phenylpyruvic acid (PPA), a multi-functional organic acid, is widely used in the pharmaceutical, food, and chemical industries.
Oct 28，2026 Pharmaceutical intermediates
Application Research of Poly-TPD
Poly-TPD has been extensively investigated for applications in perovskite photovoltaics, light-emitting diodes and organic photodetectors.
Oct 20，2026 Pharmaceutical intermediates
PEDOT:PSS: Properties, Conductivity, Applications, and Uses
PEDOT:PSS is a versatile conductive polymer with applications across electronics, flexible devices, textiles, bioelectronics, and thermoelectric systems.
Sep 22，2026 Pharmaceutical intermediates
Trichloroethanol: Properties, Detection and Multi-field Applications
Trichloroethanol possesses unique physicochemical properties and broad biological activity, enabling it to play a significant role in fields such as organic synthesis, pharmacology and environmental s
Sep 17，2026 Pharmaceutical intermediates
Tianeptine sulfate: Pharmacology, Safety and Regulatory
Tianeptine sulfate is known to increase serotonin reuptake, leading to some confusion as to its action as an antidepressant.
Sep 12，2026 Pharmaceutical intermediates
Macitentan:Dosage, Administration and Side Effect
Macitentan is an endothelin receptor antagonist used to treat pulmonary arterial hypertension (PAH) in adults.
Sep 9，2026 Pharmaceutical intermediates
PNU-159682: Metabolism, DNA Damage Mechanism and ADC Development Against Leukemia
PNU-159682 generates via hepatic metabolism, damages DNA and serves as potent ADC payload for acute lymphoblastic leukemia therapy.
Aug 13，2026 Pharmaceutical intermediates
Lewis Structure and Molecular Properties of C2Br2
Dibromoacetylene (C2Br2) is a linear, unsaturated haloalkyne compound and is a nonpolar molecule.
Jul 21，2026 Pharmaceutical intermediates
Lewis Structure Analysis of CH3COCN
CH3COCN is an organic molecule containing methyl, carbonyl, and cyano functional groups.
Jul 16，2026 Pharmaceutical intermediates